ALTME.PA PAR
TME Pharma N.V.
1W: -1.9%
1M: -8.0%
3M: +48.2%
YTD: +26.5%
1Y: +1.0%
3Y: -93.9%
5Y: -99.7%
€0.10 ($0.12)
-0.00 (-0.39%)
Weekly Expected Move ±9.8%
€0
€0
€0
€0
€0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
📊 Key Metrics
TTM€0M
Revenue
+11.8% YoY
€-9M
Net Income
+58.8% YoY
€-8M
Free Cash Flow
+33.8% YoY
29.6%
Gross Margin
3522.2%
Op. Margin
4381.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE961.8%
ROA-389.1%
ROIC688.6%
Valuation
P/E-3.0
P/B-6.1
EV/EBITDA-0.8
Leverage
Debt/Equity-1.68
Current Ratio0.57
Interest Cov.-5.1x
Quality Scores
Piotroski F3/9
Altman Z-145.57
Beneish M0.00